Dong-A, Astellas Korea cooperate over co-promotion of Irribow

Published: 2010-09-27 06:59:00
Updated: 2010-09-27 06:59:00
Dong-A Pharmaceutical has joined hands with Astellas Pharma Korea to make a joint marketing of Irribow (ramosetron), serotonin 5-HT3 receptor antagonist which is indicated for diarrhea-predominant irritable bowel syndrome in male.

To this end, both firms signed a co-promotion agreement on Sept...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.